Abstract

Lung cancer accounts for the greatest number of cancer-related mortality, while the accurate evaluation of pulmonary nodules in computed tomography (CT) images can significantly increase the 5-year relative survival rate. Despite deep learning methods that have recently been introduced to the identification of malignant nodules, a substantial challenge remains due to the limited datasets. In this study, we propose a cascaded-recalibrated multiple instance learning (MIL) model based on multiattribute features transfer for pathologic-level lung cancer prediction in CT images. This cascaded-recalibrated MIL deep model incorporates a cascaded recalibration mechanism at the nodule level and attribute level, which fuses the informative attribute features into nodule embeddings and then the key nodule features can be converged into the patient-level embedding to improve the performance of lung cancer prediction. We evaluated the proposed cascaded-recalibrated MIL model on the public Lung Image Database Consortium and Image Database Resource Initiative (LIDC-IDRI) benchmark dataset and compared it to the latest approaches. The experimental results showed a significant performance boost by the cascaded-recalibrated MIL model over the higher-order transfer learning, instance-space MIL, and embedding-space MIL models and the radiologists. In addition, the recalibration coefficients of the nodule and attribute feature for the final decision were also analyzed to reveal the underlying relationship between the confirmed diagnosis and its highly-correlated attributes. The cascaded recalibration mechanism enables the MIL model to pay more attention to those important nodules and attributes while suppressing less-useful feature embeddings, and the cascaded-recalibrated MIL model provides substantial improvements for the pathologic-level lung cancer prediction by using the CT images. The identification of the important nodules and attributes also provides better interpretability for model decision-making, which is very important for medical applications.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.